Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 171,272
  • Shares Outstanding, K 132,769
  • Annual Sales, $ 42,220 K
  • Annual Income, $ -75,750 K
  • 60-Month Beta 1.18
  • Price/Sales 3.77
  • Price/Cash Flow N/A
  • Price/Book 1.57
Trade ADMA with:

Options Overview

Details
  • Implied Volatility 131.72%
  • Historical Volatility 52.03%
  • IV Percentile 93%
  • IV Rank 53.37%
  • IV High 207.61% on 08/06/21
  • IV Low 44.87% on 09/01/21
  • Put/Call Vol Ratio 0.06
  • Today's Volume 834
  • Volume Avg (30-Day) 676
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 17,491
  • Open Int (30-Day) 18,146

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.14
  • Low Estimate -0.18
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +21.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1500 +12.17%
on 09/14/21
1.4200 -9.15%
on 08/26/21
-0.0400 (-3.01%)
since 08/17/21
3-Month
1.1500 +12.17%
on 09/14/21
1.7900 -27.93%
on 06/18/21
-0.5000 (-27.93%)
since 06/17/21
52-Week
1.1500 +12.17%
on 09/14/21
3.1105 -58.53%
on 02/10/21
-1.1200 (-46.47%)
since 09/17/20

Most Recent Stories

More News
AIM CEO Thomas K. Equels Named to Board of Directors of BioFlorida Inc.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that CEO Thomas K. Equels has been appointed to the Board of Directors of BioFlorida Inc., the state's life sciences industry association.

ADMA : 1.2900 (+7.50%)
SRTSU : 6.45 (-0.77%)
AIM : 2.0400 (+3.55%)
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced...

ADMA : 1.2900 (+7.50%)
Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 0.00% and 7.73%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ADMA : 1.2900 (+7.50%)
Adma Biologics: Q2 Earnings Snapshot

RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Wednesday reported a loss of $18.9 million in its second quarter.

ADMA : 1.2900 (+7.50%)
ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

Achieved Record Total Revenues of $17.8 Million in Second Quarter 2021, a 129% Increase Over Second Quarter 2020

ADMA : 1.2900 (+7.50%)
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics' Persona Technology for NexSys Plasma Collection System

ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the commencement...

HAE : 70.22 (+2.77%)
ADMA : 1.2900 (+7.50%)
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM(R) and NABI-HB(R)

ADMA Expands Commercial IG Product Offering with Additional BIVIGAM and NABI-HB Vial Sizes

ADMA : 1.2900 (+7.50%)
ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021

ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics,...

ADMA : 1.2900 (+7.50%)
ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

Approval for VanRx Fill-Finish Machine Expected in the Second Half of 2021

ADMA : 1.2900 (+7.50%)
ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

ADMA Biologics, Inc. (Nasdaq: ADMA) (the "Company"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced...

ADMA : 1.2900 (+7.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying...

See More

Key Turning Points

3rd Resistance Point 1.4300
2nd Resistance Point 1.3600
1st Resistance Point 1.3250
Last Price 1.2900
1st Support Level 1.2200
2nd Support Level 1.1500
3rd Support Level 1.1150

See More

52-Week High 3.1105
Fibonacci 61.8% 2.3616
Fibonacci 50% 2.1302
Fibonacci 38.2% 1.8989
Last Price 1.2900
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar